Latest International Growth News

Premier Investments reported a 31% jump in net profit to $338.2 million for FY25, driven by the sale of Just Group and a $1.03 billion fully franked In-Specie Distribution to shareholders. Continuing operations showed a profit decline amid strategic brand investments.

Decidr AI Industries has successfully completed a $20 million placement, positioning itself to accelerate international growth and advance its AI technology platform.

Epsilon Healthcare’s manufacturing arm has secured updated GMP certificates covering domestic and EU/UK markets, reinforcing its quality credentials and paving the way for expanded international contract manufacturing.

Spacetalk Ltd has raised $4.05 million through a combination of a conditional placement and convertible notes to accelerate its geographic expansion and app development, alongside appointing a seasoned director to its board.

Bioxyne Limited has secured import permits and purchase orders worth A$5.1 million for medical cannabis in Germany, signaling strong early traction in a key European market.

Prophecy International Holdings Ltd has announced the immediate resignation of CEO Brad Thomas, with Chairman Ed Reynolds stepping in as acting CEO during the leadership transition.

My Rewards International Limited has announced a pro-rata entitlement offer aiming to raise up to $4.1 million, a key step toward meeting ASX reinstatement conditions after a prolonged trading suspension. The offer includes a debt conversion proposal and is partially underwritten by major shareholders.

Red Sky Energy has formalized its 35% interest in Angola’s Block 6/24 following parliamentary ratification of the Risk Service Contract, unlocking access to significant oil resources and advancing its international growth strategy.

Biome Australia has partnered with Green Cross Health to launch its Activated Probiotics across New Zealand’s largest pharmacy network, marking a pivotal step in its international growth strategy.

Beacon Minerals has sold a significant portion of its Astral Resources shares, raising $5.9 million to support development at its Jaurdi Mill and Iguana projects.

Imricor Medical Systems has taken a significant step toward U.S. market entry by submitting its Vision-MR Diagnostic Catheter for FDA 510(k) approval, complementing its recent NorthStar system filing. These moves aim to establish a fully integrated MRI-guided cardiac ablation platform.

Hydrix Limited narrowed its FY2025 loss to $2.92 million, driven by significant cost reductions and steady revenue from expanding international medtech clients. Despite ongoing challenges in sales cycles and funding, the company remains focused on innovation and strategic investments.